These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18258828)

  • 1. Statin therapy for stroke prevention.
    Nassief A; Marsh JD
    Stroke; 2008 Mar; 39(3):1042-8. PubMed ID: 18258828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy.
    Wiviott SD; Cannon CP
    Curr Opin Lipidol; 2006 Dec; 17(6):626-30. PubMed ID: 17095906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins for the prevention of first or recurrent stroke.
    Athyros VG; Kakafika AI; Tziomalos K; Papageorgiou AA; Karagiannis A
    Curr Vasc Pharmacol; 2008 Apr; 6(2):124-33. PubMed ID: 18393914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry.
    Xian Y; Navar AM; Li S; Li Z; Robinson J; Virani SS; Louie MJ; Koren A; Goldberg A; Roger VL; Wilson PWF; Peterson ED; Wang TY
    J Am Heart Assoc; 2019 Oct; 8(19):e013229. PubMed ID: 31554462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins in hemorrhagic stroke.
    Flaster M; Morales-Vidal S; Schneck MJ; Biller J
    Expert Rev Neurother; 2011 Aug; 11(8):1141-9. PubMed ID: 21797655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials: Evidence and unanswered questions--hyperlipidaemia.
    Deanfield JE
    Cerebrovasc Dis; 2003; 16 Suppl 3():25-32. PubMed ID: 12740553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Statins in the secondary prevention of stroke: New evidence from the SPARCL Study].
    Castilla-Guerra L; Fernández-Moreno Mdel C; López-Chozas JM
    Clin Investig Arterioscler; 2016; 28(4):202-8. PubMed ID: 26150172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Goldstein LB; Amarenco P; Zivin J; Messig M; Altafullah I; Callahan A; Hennerici M; MacLeod MJ; Sillesen H; Zweifler R; Michael K; Welch A;
    Stroke; 2009 Nov; 40(11):3526-31. PubMed ID: 19745172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy and stroke prevention: what was known, what is new and what is next?
    Mazighi M; Lavallée PC; Labreuche J; Amarenco P
    Curr Opin Lipidol; 2007 Dec; 18(6):622-5. PubMed ID: 17993806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
    Sillesen H; Amarenco P; Hennerici MG; Callahan A; Goldstein LB; Zivin J; Messig M; Welch KM;
    Stroke; 2008 Dec; 39(12):3297-302. PubMed ID: 18845807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS; Bissonnette S; Habib R; Boukas S;
    Ann Pharmacother; 2007 Sep; 41(9):1345-51. PubMed ID: 17666579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy and the risk of intracerebral hemorrhage: a meta-analysis of 31 randomized controlled trials.
    McKinney JS; Kostis WJ
    Stroke; 2012 Aug; 43(8):2149-56. PubMed ID: 22588266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Statin Therapy in Hemorrhagic Stroke.
    Sikora Newsome A; Casciere BC; Jordan JD; Rhoney DH; Sullivan KA; Morbitzer KA; Moore JD; Durr EA
    Pharmacotherapy; 2015 Dec; 35(12):1152-63. PubMed ID: 26684555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of statins on risk of stroke: a meta-analysis.
    Henyan NN; Riche DM; East HE; Gann PN
    Ann Pharmacother; 2007 Dec; 41(12):1937-45. PubMed ID: 17986516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug insight: translating evidence on statin therapy into clinical benefits.
    Sanossian N; Ovbiagele B
    Nat Clin Pract Neurol; 2008 Jan; 4(1):43-9. PubMed ID: 18199996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage.
    Ma Y; Li Z; Chen L; Li X
    Lipids Health Dis; 2016 Mar; 15():43. PubMed ID: 26932585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease.
    Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
    Stroke; 2008 Feb; 39(2):497-502. PubMed ID: 18174491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.